nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—CYP2D6—epilepsy syndrome	0.479	1	CbGaD
Nebivolol—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00491	0.163	CbGeAlD
Nebivolol—HTR1A—ganglion—epilepsy syndrome	0.00305	0.102	CbGeAlD
Nebivolol—HTR1A—hindbrain—epilepsy syndrome	0.00232	0.0771	CbGeAlD
Nebivolol—ADRB1—forebrain—epilepsy syndrome	0.00149	0.0497	CbGeAlD
Nebivolol—ADRB1—telencephalon—epilepsy syndrome	0.00137	0.0457	CbGeAlD
Nebivolol—HTR1A—brainstem—epilepsy syndrome	0.00133	0.0442	CbGeAlD
Nebivolol—HTR1A—forebrain—epilepsy syndrome	0.00128	0.0426	CbGeAlD
Nebivolol—CYP2D6—hindbrain—epilepsy syndrome	0.00126	0.0418	CbGeAlD
Nebivolol—HTR1A—telencephalon—epilepsy syndrome	0.00118	0.0392	CbGeAlD
Nebivolol—ADRB1—head—epilepsy syndrome	0.000855	0.0285	CbGeAlD
Nebivolol—HTR1A—midbrain—epilepsy syndrome	0.000846	0.0281	CbGeAlD
Nebivolol—HTR1A—spinal cord—epilepsy syndrome	0.000825	0.0275	CbGeAlD
Nebivolol—ADRB1—nervous system—epilepsy syndrome	0.000811	0.027	CbGeAlD
Nebivolol—ADRB1—central nervous system—epilepsy syndrome	0.000781	0.026	CbGeAlD
Nebivolol—HTR1A—head—epilepsy syndrome	0.000734	0.0244	CbGeAlD
Nebivolol—CYP2D6—brainstem—epilepsy syndrome	0.000721	0.024	CbGeAlD
Nebivolol—CYP2D6—forebrain—epilepsy syndrome	0.000696	0.0231	CbGeAlD
Nebivolol—HTR1A—nervous system—epilepsy syndrome	0.000696	0.0231	CbGeAlD
Nebivolol—HTR1A—central nervous system—epilepsy syndrome	0.00067	0.0223	CbGeAlD
Nebivolol—HTR1A—cerebellum—epilepsy syndrome	0.000655	0.0218	CbGeAlD
Nebivolol—CYP2D6—telencephalon—epilepsy syndrome	0.00064	0.0213	CbGeAlD
Nebivolol—ADRB1—brain—epilepsy syndrome	0.00062	0.0206	CbGeAlD
Nebivolol—HTR1A—brain—epilepsy syndrome	0.000532	0.0177	CbGeAlD
Nebivolol—CYP2D6—head—epilepsy syndrome	0.000398	0.0133	CbGeAlD
Nebivolol—Dizziness—Propofol—epilepsy syndrome	0.000388	0.00115	CcSEcCtD
Nebivolol—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000388	0.00115	CcSEcCtD
Nebivolol—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000388	0.00115	CcSEcCtD
Nebivolol—Pruritus—Fosphenytoin—epilepsy syndrome	0.000387	0.00115	CcSEcCtD
Nebivolol—Hypersensitivity—Diazepam—epilepsy syndrome	0.000387	0.00115	CcSEcCtD
Nebivolol—Malnutrition—Pregabalin—epilepsy syndrome	0.000387	0.00115	CcSEcCtD
Nebivolol—Vertigo—Valproic Acid—epilepsy syndrome	0.000384	0.00114	CcSEcCtD
Nebivolol—Asthenia—Vigabatrin—epilepsy syndrome	0.000383	0.00114	CcSEcCtD
Nebivolol—Urticaria—Clonazepam—epilepsy syndrome	0.000381	0.00113	CcSEcCtD
Nebivolol—Dizziness—Midazolam—epilepsy syndrome	0.00038	0.00113	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000379	0.00113	CcSEcCtD
Nebivolol—Abdominal pain—Clonazepam—epilepsy syndrome	0.000379	0.00113	CcSEcCtD
Nebivolol—Fatigue—Lamotrigine—epilepsy syndrome	0.000379	0.00113	CcSEcCtD
Nebivolol—Urticaria—Phenytoin—epilepsy syndrome	0.000378	0.00112	CcSEcCtD
Nebivolol—Cardiac disorder—Gabapentin—epilepsy syndrome	0.000378	0.00112	CcSEcCtD
Nebivolol—CYP2D6—nervous system—epilepsy syndrome	0.000378	0.0126	CbGeAlD
Nebivolol—Pruritus—Vigabatrin—epilepsy syndrome	0.000377	0.00112	CcSEcCtD
Nebivolol—Asthenia—Diazepam—epilepsy syndrome	0.000377	0.00112	CcSEcCtD
Nebivolol—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000376	0.00112	CcSEcCtD
Nebivolol—Nausea—Acetazolamide—epilepsy syndrome	0.000375	0.00112	CcSEcCtD
Nebivolol—Dizziness—Levetiracetam—epilepsy syndrome	0.000375	0.00111	CcSEcCtD
Nebivolol—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000375	0.00111	CcSEcCtD
Nebivolol—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000375	0.00111	CcSEcCtD
Nebivolol—Vomiting—Propofol—epilepsy syndrome	0.000373	0.00111	CcSEcCtD
Nebivolol—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000372	0.00111	CcSEcCtD
Nebivolol—Pruritus—Diazepam—epilepsy syndrome	0.000372	0.0011	CcSEcCtD
Nebivolol—Rash—Propofol—epilepsy syndrome	0.00037	0.0011	CcSEcCtD
Nebivolol—Dermatitis—Propofol—epilepsy syndrome	0.00037	0.0011	CcSEcCtD
Nebivolol—Headache—Propofol—epilepsy syndrome	0.000368	0.00109	CcSEcCtD
Nebivolol—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000367	0.00109	CcSEcCtD
Nebivolol—Vomiting—Midazolam—epilepsy syndrome	0.000365	0.00109	CcSEcCtD
Nebivolol—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000365	0.00108	CcSEcCtD
Nebivolol—Asthenia—Felbamate—epilepsy syndrome	0.000365	0.00108	CcSEcCtD
Nebivolol—Chest pain—Valproic Acid—epilepsy syndrome	0.000364	0.00108	CcSEcCtD
Nebivolol—CYP2D6—central nervous system—epilepsy syndrome	0.000364	0.0121	CbGeAlD
Nebivolol—Rash—Midazolam—epilepsy syndrome	0.000362	0.00108	CcSEcCtD
Nebivolol—Dizziness—Fosphenytoin—epilepsy syndrome	0.000362	0.00108	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000362	0.00108	CcSEcCtD
Nebivolol—Dermatitis—Midazolam—epilepsy syndrome	0.000362	0.00108	CcSEcCtD
Nebivolol—Urticaria—Carbamazepine—epilepsy syndrome	0.000361	0.00107	CcSEcCtD
Nebivolol—Vomiting—Levetiracetam—epilepsy syndrome	0.000361	0.00107	CcSEcCtD
Nebivolol—Headache—Midazolam—epilepsy syndrome	0.00036	0.00107	CcSEcCtD
Nebivolol—Pruritus—Felbamate—epilepsy syndrome	0.00036	0.00107	CcSEcCtD
Nebivolol—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000359	0.00107	CcSEcCtD
Nebivolol—Diarrhoea—Diazepam—epilepsy syndrome	0.000359	0.00107	CcSEcCtD
Nebivolol—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000359	0.00107	CcSEcCtD
Nebivolol—Rash—Levetiracetam—epilepsy syndrome	0.000358	0.00106	CcSEcCtD
Nebivolol—Dermatitis—Levetiracetam—epilepsy syndrome	0.000357	0.00106	CcSEcCtD
Nebivolol—Asthenia—Zonisamide—epilepsy syndrome	0.000357	0.00106	CcSEcCtD
Nebivolol—Mental disorder—Gabapentin—epilepsy syndrome	0.000357	0.00106	CcSEcCtD
Nebivolol—CYP2D6—cerebellum—epilepsy syndrome	0.000355	0.0118	CbGeAlD
Nebivolol—Headache—Levetiracetam—epilepsy syndrome	0.000355	0.00106	CcSEcCtD
Nebivolol—Malnutrition—Gabapentin—epilepsy syndrome	0.000355	0.00105	CcSEcCtD
Nebivolol—Angioedema—Pregabalin—epilepsy syndrome	0.000353	0.00105	CcSEcCtD
Nebivolol—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000353	0.00105	CcSEcCtD
Nebivolol—Dizziness—Vigabatrin—epilepsy syndrome	0.000353	0.00105	CcSEcCtD
Nebivolol—Pruritus—Zonisamide—epilepsy syndrome	0.000352	0.00105	CcSEcCtD
Nebivolol—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000351	0.00104	CcSEcCtD
Nebivolol—Urticaria—Lamotrigine—epilepsy syndrome	0.000349	0.00104	CcSEcCtD
Nebivolol—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000349	0.00104	CcSEcCtD
Nebivolol—Bradycardia—Topiramate—epilepsy syndrome	0.000349	0.00104	CcSEcCtD
Nebivolol—Nausea—Propofol—epilepsy syndrome	0.000349	0.00104	CcSEcCtD
Nebivolol—Vomiting—Fosphenytoin—epilepsy syndrome	0.000348	0.00103	CcSEcCtD
Nebivolol—Diarrhoea—Felbamate—epilepsy syndrome	0.000348	0.00103	CcSEcCtD
Nebivolol—Vertigo—Pregabalin—epilepsy syndrome	0.000348	0.00103	CcSEcCtD
Nebivolol—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000347	0.00103	CcSEcCtD
Nebivolol—Dizziness—Diazepam—epilepsy syndrome	0.000347	0.00103	CcSEcCtD
Nebivolol—Syncope—Pregabalin—epilepsy syndrome	0.000347	0.00103	CcSEcCtD
Nebivolol—Rash—Fosphenytoin—epilepsy syndrome	0.000345	0.00103	CcSEcCtD
Nebivolol—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000345	0.00102	CcSEcCtD
Nebivolol—Asthenia—Clonazepam—epilepsy syndrome	0.000344	0.00102	CcSEcCtD
Nebivolol—Headache—Fosphenytoin—epilepsy syndrome	0.000343	0.00102	CcSEcCtD
Nebivolol—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000342	0.00102	CcSEcCtD
Nebivolol—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000342	0.00102	CcSEcCtD
Nebivolol—Asthenia—Phenytoin—epilepsy syndrome	0.000342	0.00102	CcSEcCtD
Nebivolol—Nausea—Midazolam—epilepsy syndrome	0.000341	0.00101	CcSEcCtD
Nebivolol—Diarrhoea—Zonisamide—epilepsy syndrome	0.000341	0.00101	CcSEcCtD
Nebivolol—Loss of consciousness—Pregabalin—epilepsy syndrome	0.00034	0.00101	CcSEcCtD
Nebivolol—Asthenia—Oxcarbazepine—epilepsy syndrome	0.00034	0.00101	CcSEcCtD
Nebivolol—Pruritus—Clonazepam—epilepsy syndrome	0.000339	0.00101	CcSEcCtD
Nebivolol—Vomiting—Vigabatrin—epilepsy syndrome	0.000339	0.00101	CcSEcCtD
Nebivolol—Skin disorder—Valproic Acid—epilepsy syndrome	0.000339	0.00101	CcSEcCtD
Nebivolol—Oedema peripheral—Topiramate—epilepsy syndrome	0.000338	0.001	CcSEcCtD
Nebivolol—Pruritus—Phenytoin—epilepsy syndrome	0.000337	0.001	CcSEcCtD
Nebivolol—Nausea—Levetiracetam—epilepsy syndrome	0.000337	0.001	CcSEcCtD
Nebivolol—Rash—Vigabatrin—epilepsy syndrome	0.000336	0.001	CcSEcCtD
Nebivolol—Dizziness—Felbamate—epilepsy syndrome	0.000336	0.000999	CcSEcCtD
Nebivolol—Dermatitis—Vigabatrin—epilepsy syndrome	0.000336	0.000999	CcSEcCtD
Nebivolol—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000335	0.000996	CcSEcCtD
Nebivolol—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000335	0.000996	CcSEcCtD
Nebivolol—Headache—Vigabatrin—epilepsy syndrome	0.000334	0.000993	CcSEcCtD
Nebivolol—Vomiting—Diazepam—epilepsy syndrome	0.000334	0.000992	CcSEcCtD
Nebivolol—Rash—Diazepam—epilepsy syndrome	0.000331	0.000984	CcSEcCtD
Nebivolol—Dermatitis—Diazepam—epilepsy syndrome	0.000331	0.000983	CcSEcCtD
Nebivolol—Chest pain—Pregabalin—epilepsy syndrome	0.000329	0.000979	CcSEcCtD
Nebivolol—Dizziness—Zonisamide—epilepsy syndrome	0.000329	0.000978	CcSEcCtD
Nebivolol—Headache—Diazepam—epilepsy syndrome	0.000329	0.000978	CcSEcCtD
Nebivolol—Diarrhoea—Clonazepam—epilepsy syndrome	0.000328	0.000975	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000327	0.000972	CcSEcCtD
Nebivolol—Asthenia—Carbamazepine—epilepsy syndrome	0.000326	0.00097	CcSEcCtD
Nebivolol—Diarrhoea—Phenytoin—epilepsy syndrome	0.000326	0.000969	CcSEcCtD
Nebivolol—Nausea—Fosphenytoin—epilepsy syndrome	0.000325	0.000966	CcSEcCtD
Nebivolol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000324	0.000963	CcSEcCtD
Nebivolol—Angioedema—Gabapentin—epilepsy syndrome	0.000324	0.000963	CcSEcCtD
Nebivolol—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000324	0.000962	CcSEcCtD
Nebivolol—Vomiting—Felbamate—epilepsy syndrome	0.000323	0.000961	CcSEcCtD
Nebivolol—Pruritus—Carbamazepine—epilepsy syndrome	0.000322	0.000956	CcSEcCtD
Nebivolol—Rash—Felbamate—epilepsy syndrome	0.000321	0.000953	CcSEcCtD
Nebivolol—Dermatitis—Felbamate—epilepsy syndrome	0.00032	0.000952	CcSEcCtD
Nebivolol—Vertigo—Gabapentin—epilepsy syndrome	0.000319	0.000947	CcSEcCtD
Nebivolol—Headache—Felbamate—epilepsy syndrome	0.000319	0.000946	CcSEcCtD
Nebivolol—Cardiac disorder—Topiramate—epilepsy syndrome	0.000318	0.000946	CcSEcCtD
Nebivolol—Syncope—Gabapentin—epilepsy syndrome	0.000318	0.000945	CcSEcCtD
Nebivolol—Dizziness—Clonazepam—epilepsy syndrome	0.000317	0.000942	CcSEcCtD
Nebivolol—Nausea—Vigabatrin—epilepsy syndrome	0.000317	0.000942	CcSEcCtD
Nebivolol—Vomiting—Zonisamide—epilepsy syndrome	0.000316	0.00094	CcSEcCtD
Nebivolol—Insomnia—Valproic Acid—epilepsy syndrome	0.000316	0.000939	CcSEcCtD
Nebivolol—Asthenia—Lamotrigine—epilepsy syndrome	0.000315	0.000937	CcSEcCtD
Nebivolol—Dizziness—Phenytoin—epilepsy syndrome	0.000315	0.000936	CcSEcCtD
Nebivolol—Rash—Zonisamide—epilepsy syndrome	0.000314	0.000932	CcSEcCtD
Nebivolol—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000314	0.000932	CcSEcCtD
Nebivolol—Dermatitis—Zonisamide—epilepsy syndrome	0.000313	0.000932	CcSEcCtD
Nebivolol—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000313	0.000931	CcSEcCtD
Nebivolol—Nausea—Diazepam—epilepsy syndrome	0.000312	0.000927	CcSEcCtD
Nebivolol—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000312	0.000927	CcSEcCtD
Nebivolol—Headache—Zonisamide—epilepsy syndrome	0.000312	0.000926	CcSEcCtD
Nebivolol—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000311	0.000925	CcSEcCtD
Nebivolol—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000311	0.000925	CcSEcCtD
Nebivolol—Pruritus—Lamotrigine—epilepsy syndrome	0.000311	0.000924	CcSEcCtD
Nebivolol—Shock—Pregabalin—epilepsy syndrome	0.000311	0.000923	CcSEcCtD
Nebivolol—Somnolence—Valproic Acid—epilepsy syndrome	0.00031	0.000923	CcSEcCtD
Nebivolol—Nervous system disorder—Pregabalin—epilepsy syndrome	0.00031	0.00092	CcSEcCtD
Nebivolol—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000309	0.000919	CcSEcCtD
Nebivolol—Skin disorder—Pregabalin—epilepsy syndrome	0.000307	0.000911	CcSEcCtD
Nebivolol—Vomiting—Clonazepam—epilepsy syndrome	0.000305	0.000906	CcSEcCtD
Nebivolol—Vomiting—Phenytoin—epilepsy syndrome	0.000303	0.0009	CcSEcCtD
Nebivolol—Rash—Clonazepam—epilepsy syndrome	0.000302	0.000899	CcSEcCtD
Nebivolol—Dermatitis—Clonazepam—epilepsy syndrome	0.000302	0.000898	CcSEcCtD
Nebivolol—Chest pain—Gabapentin—epilepsy syndrome	0.000302	0.000897	CcSEcCtD
Nebivolol—Nausea—Felbamate—epilepsy syndrome	0.000302	0.000897	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000302	0.000896	CcSEcCtD
Nebivolol—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000301	0.000895	CcSEcCtD
Nebivolol—Fatigue—Valproic Acid—epilepsy syndrome	0.000301	0.000895	CcSEcCtD
Nebivolol—Dizziness—Carbamazepine—epilepsy syndrome	0.000301	0.000894	CcSEcCtD
Nebivolol—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000301	0.000894	CcSEcCtD
Nebivolol—Headache—Clonazepam—epilepsy syndrome	0.0003	0.000893	CcSEcCtD
Nebivolol—Rash—Phenytoin—epilepsy syndrome	0.0003	0.000893	CcSEcCtD
Nebivolol—Mental disorder—Topiramate—epilepsy syndrome	0.0003	0.000893	CcSEcCtD
Nebivolol—Dermatitis—Phenytoin—epilepsy syndrome	0.0003	0.000892	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.0003	0.000891	CcSEcCtD
Nebivolol—Rash—Oxcarbazepine—epilepsy syndrome	0.000299	0.000888	CcSEcCtD
Nebivolol—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000299	0.000887	CcSEcCtD
Nebivolol—Headache—Phenytoin—epilepsy syndrome	0.000298	0.000887	CcSEcCtD
Nebivolol—Malnutrition—Topiramate—epilepsy syndrome	0.000298	0.000887	CcSEcCtD
Nebivolol—Headache—Oxcarbazepine—epilepsy syndrome	0.000297	0.000882	CcSEcCtD
Nebivolol—Nausea—Zonisamide—epilepsy syndrome	0.000296	0.000878	CcSEcCtD
Nebivolol—Dizziness—Lamotrigine—epilepsy syndrome	0.000291	0.000864	CcSEcCtD
Nebivolol—Vomiting—Carbamazepine—epilepsy syndrome	0.000289	0.000859	CcSEcCtD
Nebivolol—CYP2D6—brain—epilepsy syndrome	0.000289	0.0096	CbGeAlD
Nebivolol—Rash—Carbamazepine—epilepsy syndrome	0.000287	0.000852	CcSEcCtD
Nebivolol—Dermatitis—Carbamazepine—epilepsy syndrome	0.000286	0.000851	CcSEcCtD
Nebivolol—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000286	0.000849	CcSEcCtD
Nebivolol—Insomnia—Pregabalin—epilepsy syndrome	0.000286	0.000849	CcSEcCtD
Nebivolol—Nausea—Clonazepam—epilepsy syndrome	0.000285	0.000847	CcSEcCtD
Nebivolol—Headache—Carbamazepine—epilepsy syndrome	0.000285	0.000847	CcSEcCtD
Nebivolol—Shock—Gabapentin—epilepsy syndrome	0.000285	0.000846	CcSEcCtD
Nebivolol—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000284	0.000844	CcSEcCtD
Nebivolol—Paraesthesia—Pregabalin—epilepsy syndrome	0.000284	0.000842	CcSEcCtD
Nebivolol—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000283	0.000842	CcSEcCtD
Nebivolol—Nausea—Phenytoin—epilepsy syndrome	0.000283	0.000841	CcSEcCtD
Nebivolol—Dyspnoea—Pregabalin—epilepsy syndrome	0.000281	0.000836	CcSEcCtD
Nebivolol—Nausea—Oxcarbazepine—epilepsy syndrome	0.000281	0.000836	CcSEcCtD
Nebivolol—Skin disorder—Gabapentin—epilepsy syndrome	0.000281	0.000836	CcSEcCtD
Nebivolol—Somnolence—Pregabalin—epilepsy syndrome	0.000281	0.000834	CcSEcCtD
Nebivolol—Vomiting—Lamotrigine—epilepsy syndrome	0.000279	0.00083	CcSEcCtD
Nebivolol—Urticaria—Valproic Acid—epilepsy syndrome	0.000277	0.000824	CcSEcCtD
Nebivolol—Rash—Lamotrigine—epilepsy syndrome	0.000277	0.000823	CcSEcCtD
Nebivolol—Dermatitis—Lamotrigine—epilepsy syndrome	0.000277	0.000823	CcSEcCtD
Nebivolol—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000276	0.00082	CcSEcCtD
Nebivolol—Headache—Lamotrigine—epilepsy syndrome	0.000275	0.000818	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000273	0.00081	CcSEcCtD
Nebivolol—Fatigue—Pregabalin—epilepsy syndrome	0.000272	0.000809	CcSEcCtD
Nebivolol—Nausea—Carbamazepine—epilepsy syndrome	0.00027	0.000803	CcSEcCtD
Nebivolol—Vertigo—Topiramate—epilepsy syndrome	0.000268	0.000797	CcSEcCtD
Nebivolol—Syncope—Topiramate—epilepsy syndrome	0.000268	0.000795	CcSEcCtD
Nebivolol—Loss of consciousness—Topiramate—epilepsy syndrome	0.000262	0.000779	CcSEcCtD
Nebivolol—Insomnia—Gabapentin—epilepsy syndrome	0.000262	0.000778	CcSEcCtD
Nebivolol—Nausea—Lamotrigine—epilepsy syndrome	0.000261	0.000776	CcSEcCtD
Nebivolol—Paraesthesia—Gabapentin—epilepsy syndrome	0.00026	0.000773	CcSEcCtD
Nebivolol—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000258	0.000767	CcSEcCtD
Nebivolol—Dyspnoea—Gabapentin—epilepsy syndrome	0.000258	0.000767	CcSEcCtD
Nebivolol—Somnolence—Gabapentin—epilepsy syndrome	0.000257	0.000765	CcSEcCtD
Nebivolol—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000257	0.000765	CcSEcCtD
Nebivolol—Chest pain—Topiramate—epilepsy syndrome	0.000254	0.000755	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000252	0.00075	CcSEcCtD
Nebivolol—Urticaria—Pregabalin—epilepsy syndrome	0.000251	0.000745	CcSEcCtD
Nebivolol—Asthenia—Valproic Acid—epilepsy syndrome	0.000251	0.000745	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.00025	0.000743	CcSEcCtD
Nebivolol—Fatigue—Gabapentin—epilepsy syndrome	0.00025	0.000742	CcSEcCtD
Nebivolol—Abdominal pain—Pregabalin—epilepsy syndrome	0.00025	0.000742	CcSEcCtD
Nebivolol—Pruritus—Valproic Acid—epilepsy syndrome	0.000247	0.000734	CcSEcCtD
Nebivolol—Shock—Topiramate—epilepsy syndrome	0.00024	0.000712	CcSEcCtD
Nebivolol—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000239	0.00071	CcSEcCtD
Nebivolol—Nervous system disorder—Topiramate—epilepsy syndrome	0.000239	0.00071	CcSEcCtD
Nebivolol—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000238	0.000709	CcSEcCtD
Nebivolol—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000237	0.000704	CcSEcCtD
Nebivolol—Skin disorder—Topiramate—epilepsy syndrome	0.000237	0.000703	CcSEcCtD
Nebivolol—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000233	0.000691	CcSEcCtD
Nebivolol—Dizziness—Valproic Acid—epilepsy syndrome	0.000231	0.000686	CcSEcCtD
Nebivolol—Urticaria—Gabapentin—epilepsy syndrome	0.00023	0.000683	CcSEcCtD
Nebivolol—Abdominal pain—Gabapentin—epilepsy syndrome	0.000229	0.00068	CcSEcCtD
Nebivolol—Asthenia—Pregabalin—epilepsy syndrome	0.000227	0.000673	CcSEcCtD
Nebivolol—Pruritus—Pregabalin—epilepsy syndrome	0.000223	0.000664	CcSEcCtD
Nebivolol—Vomiting—Valproic Acid—epilepsy syndrome	0.000222	0.00066	CcSEcCtD
Nebivolol—Insomnia—Topiramate—epilepsy syndrome	0.00022	0.000655	CcSEcCtD
Nebivolol—Rash—Valproic Acid—epilepsy syndrome	0.00022	0.000654	CcSEcCtD
Nebivolol—Dermatitis—Valproic Acid—epilepsy syndrome	0.00022	0.000654	CcSEcCtD
Nebivolol—Headache—Valproic Acid—epilepsy syndrome	0.000219	0.00065	CcSEcCtD
Nebivolol—Paraesthesia—Topiramate—epilepsy syndrome	0.000219	0.00065	CcSEcCtD
Nebivolol—Dyspnoea—Topiramate—epilepsy syndrome	0.000217	0.000645	CcSEcCtD
Nebivolol—Somnolence—Topiramate—epilepsy syndrome	0.000217	0.000643	CcSEcCtD
Nebivolol—Diarrhoea—Pregabalin—epilepsy syndrome	0.000216	0.000642	CcSEcCtD
Nebivolol—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000213	0.000634	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.00021	0.000625	CcSEcCtD
Nebivolol—Fatigue—Topiramate—epilepsy syndrome	0.00021	0.000624	CcSEcCtD
Nebivolol—Dizziness—Pregabalin—epilepsy syndrome	0.000209	0.00062	CcSEcCtD
Nebivolol—Asthenia—Gabapentin—epilepsy syndrome	0.000208	0.000617	CcSEcCtD
Nebivolol—Nausea—Valproic Acid—epilepsy syndrome	0.000207	0.000616	CcSEcCtD
Nebivolol—Pruritus—Gabapentin—epilepsy syndrome	0.000205	0.000609	CcSEcCtD
Nebivolol—Vomiting—Pregabalin—epilepsy syndrome	0.000201	0.000597	CcSEcCtD
Nebivolol—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000199	0.000592	CcSEcCtD
Nebivolol—Rash—Pregabalin—epilepsy syndrome	0.000199	0.000592	CcSEcCtD
Nebivolol—Dermatitis—Pregabalin—epilepsy syndrome	0.000199	0.000591	CcSEcCtD
Nebivolol—Diarrhoea—Gabapentin—epilepsy syndrome	0.000198	0.000589	CcSEcCtD
Nebivolol—Headache—Pregabalin—epilepsy syndrome	0.000198	0.000588	CcSEcCtD
Nebivolol—Urticaria—Topiramate—epilepsy syndrome	0.000194	0.000575	CcSEcCtD
Nebivolol—Abdominal pain—Topiramate—epilepsy syndrome	0.000193	0.000572	CcSEcCtD
Nebivolol—Dizziness—Gabapentin—epilepsy syndrome	0.000191	0.000569	CcSEcCtD
Nebivolol—Nausea—Pregabalin—epilepsy syndrome	0.000188	0.000557	CcSEcCtD
Nebivolol—Vomiting—Gabapentin—epilepsy syndrome	0.000184	0.000547	CcSEcCtD
Nebivolol—Rash—Gabapentin—epilepsy syndrome	0.000183	0.000542	CcSEcCtD
Nebivolol—Dermatitis—Gabapentin—epilepsy syndrome	0.000182	0.000542	CcSEcCtD
Nebivolol—Headache—Gabapentin—epilepsy syndrome	0.000181	0.000539	CcSEcCtD
Nebivolol—Hypersensitivity—Topiramate—epilepsy syndrome	0.000179	0.000533	CcSEcCtD
Nebivolol—Asthenia—Topiramate—epilepsy syndrome	0.000175	0.000519	CcSEcCtD
Nebivolol—Pruritus—Topiramate—epilepsy syndrome	0.000172	0.000512	CcSEcCtD
Nebivolol—Nausea—Gabapentin—epilepsy syndrome	0.000172	0.000511	CcSEcCtD
Nebivolol—Diarrhoea—Topiramate—epilepsy syndrome	0.000167	0.000495	CcSEcCtD
Nebivolol—Dizziness—Topiramate—epilepsy syndrome	0.000161	0.000479	CcSEcCtD
Nebivolol—Vomiting—Topiramate—epilepsy syndrome	0.000155	0.00046	CcSEcCtD
Nebivolol—Rash—Topiramate—epilepsy syndrome	0.000154	0.000456	CcSEcCtD
Nebivolol—Dermatitis—Topiramate—epilepsy syndrome	0.000153	0.000456	CcSEcCtD
Nebivolol—Headache—Topiramate—epilepsy syndrome	0.000153	0.000453	CcSEcCtD
Nebivolol—Nausea—Topiramate—epilepsy syndrome	0.000145	0.00043	CcSEcCtD
Nebivolol—HTR1A—Signaling Pathways—CX3CL1—epilepsy syndrome	3.37e-05	0.000218	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CDC42—epilepsy syndrome	3.37e-05	0.000218	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GABBR1—epilepsy syndrome	3.35e-05	0.000217	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AVP—epilepsy syndrome	3.33e-05	0.000215	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CDC42—epilepsy syndrome	3.29e-05	0.000213	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HRH3—epilepsy syndrome	3.28e-05	0.000212	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GABBR1—epilepsy syndrome	3.28e-05	0.000212	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AVP—epilepsy syndrome	3.26e-05	0.000211	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—OPRM1—epilepsy syndrome	3.23e-05	0.000209	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HRH3—epilepsy syndrome	3.21e-05	0.000208	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	3.2e-05	0.000207	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AVP—epilepsy syndrome	3.19e-05	0.000206	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—OPRM1—epilepsy syndrome	3.16e-05	0.000205	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HRH3—epilepsy syndrome	3.14e-05	0.000203	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—CCR5—epilepsy syndrome	3.12e-05	0.000202	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	3.11e-05	0.000201	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—OPRM1—epilepsy syndrome	3.09e-05	0.0002	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCR3—epilepsy syndrome	3.05e-05	0.000197	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—HTR2A—epilepsy syndrome	3.05e-05	0.000197	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	3.05e-05	0.000197	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALAD—epilepsy syndrome	3.03e-05	0.000196	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NT5E—epilepsy syndrome	3.03e-05	0.000196	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	2.99e-05	0.000193	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.99e-05	0.000193	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—CCR5—epilepsy syndrome	2.98e-05	0.000193	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	2.98e-05	0.000192	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	2.98e-05	0.000192	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCR3—epilepsy syndrome	2.92e-05	0.000189	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.92e-05	0.000189	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	2.91e-05	0.000188	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	2.91e-05	0.000188	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	2.9e-05	0.000187	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	2.9e-05	0.000187	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	2.9e-05	0.000187	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	2.87e-05	0.000186	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	2.87e-05	0.000186	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	2.87e-05	0.000186	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	2.87e-05	0.000186	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	2.87e-05	0.000186	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NPY—epilepsy syndrome	2.85e-05	0.000184	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ATP2A2—epilepsy syndrome	2.85e-05	0.000184	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	2.83e-05	0.000183	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	2.83e-05	0.000183	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	2.83e-05	0.000183	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	2.81e-05	0.000182	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	2.81e-05	0.000182	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	2.81e-05	0.000182	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	2.81e-05	0.000182	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	2.81e-05	0.000182	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ADSL—epilepsy syndrome	2.78e-05	0.00018	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	2.77e-05	0.000179	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	2.77e-05	0.000179	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AGT—epilepsy syndrome	2.77e-05	0.000179	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HSPB1—epilepsy syndrome	2.75e-05	0.000178	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—OXT—epilepsy syndrome	2.75e-05	0.000178	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CRH—epilepsy syndrome	2.75e-05	0.000178	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CXCL2—epilepsy syndrome	2.75e-05	0.000178	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCL3—epilepsy syndrome	2.75e-05	0.000178	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GLUL—epilepsy syndrome	2.72e-05	0.000176	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	2.71e-05	0.000175	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CCR5—epilepsy syndrome	2.71e-05	0.000175	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.68e-05	0.000173	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	2.67e-05	0.000173	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	2.67e-05	0.000173	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	2.67e-05	0.000173	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—HTR2A—epilepsy syndrome	2.65e-05	0.000171	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	2.63e-05	0.00017	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.62e-05	0.000169	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	2.61e-05	0.000169	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	2.61e-05	0.000169	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	2.6e-05	0.000168	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	2.6e-05	0.000168	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	2.6e-05	0.000168	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	2.57e-05	0.000166	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	2.57e-05	0.000166	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.56e-05	0.000166	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TSC1—epilepsy syndrome	2.55e-05	0.000165	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PTK2B—epilepsy syndrome	2.55e-05	0.000165	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	2.54e-05	0.000164	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	2.54e-05	0.000164	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	2.54e-05	0.000164	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	2.54e-05	0.000164	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	2.53e-05	0.000164	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	2.52e-05	0.000163	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AGT—epilepsy syndrome	2.52e-05	0.000163	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	2.5e-05	0.000162	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	2.49e-05	0.000161	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCR2—epilepsy syndrome	2.48e-05	0.000161	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SST—epilepsy syndrome	2.48e-05	0.000161	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NTRK2—epilepsy syndrome	2.48e-05	0.000161	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	2.47e-05	0.00016	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—DUSP6—epilepsy syndrome	2.46e-05	0.000159	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	2.44e-05	0.000158	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	2.44e-05	0.000158	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	2.44e-05	0.000158	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADRA2A—epilepsy syndrome	2.43e-05	0.000157	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	2.43e-05	0.000157	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AQP1—epilepsy syndrome	2.43e-05	0.000157	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	2.42e-05	0.000157	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PLAT—epilepsy syndrome	2.42e-05	0.000157	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	2.4e-05	0.000155	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	2.4e-05	0.000155	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	2.39e-05	0.000154	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	2.39e-05	0.000154	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	2.39e-05	0.000154	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	2.38e-05	0.000154	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	2.38e-05	0.000154	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	2.37e-05	0.000153	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	2.34e-05	0.000152	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	2.34e-05	0.000152	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	2.34e-05	0.000151	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	2.34e-05	0.000151	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CXCL12—epilepsy syndrome	2.33e-05	0.000151	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—BDKRB2—epilepsy syndrome	2.33e-05	0.000151	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—POMC—epilepsy syndrome	2.33e-05	0.000151	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PRKCB—epilepsy syndrome	2.32e-05	0.00015	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.31e-05	0.00015	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CNR1—epilepsy syndrome	2.29e-05	0.000148	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—JUNB—epilepsy syndrome	2.29e-05	0.000148	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	2.29e-05	0.000148	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PLCB1—epilepsy syndrome	2.28e-05	0.000148	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	2.27e-05	0.000147	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HTR7—epilepsy syndrome	2.24e-05	0.000145	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	2.23e-05	0.000144	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	2.22e-05	0.000144	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	2.21e-05	0.000143	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	2.19e-05	0.000142	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	2.19e-05	0.000142	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	2.18e-05	0.000141	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	2.18e-05	0.000141	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HBEGF—epilepsy syndrome	2.17e-05	0.00014	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	2.17e-05	0.00014	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	2.16e-05	0.00014	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AKT3—epilepsy syndrome	2.13e-05	0.000138	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	2.13e-05	0.000138	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	2.12e-05	0.000137	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—POMC—epilepsy syndrome	2.12e-05	0.000137	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADAM10—epilepsy syndrome	2.08e-05	0.000135	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CCL2—epilepsy syndrome	2.07e-05	0.000134	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	2.06e-05	0.000133	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	2.04e-05	0.000132	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	2.03e-05	0.000131	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	2.01e-05	0.00013	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	1.99e-05	0.000129	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	1.99e-05	0.000129	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—S100B—epilepsy syndrome	1.97e-05	0.000127	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	1.97e-05	0.000127	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	1.95e-05	0.000126	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	1.94e-05	0.000126	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	1.92e-05	0.000124	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	1.88e-05	0.000122	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	1.86e-05	0.00012	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	1.82e-05	0.000118	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	1.81e-05	0.000117	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	1.8e-05	0.000117	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	1.8e-05	0.000116	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.79e-05	0.000116	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	1.78e-05	0.000115	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	1.77e-05	0.000114	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	1.76e-05	0.000114	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	1.76e-05	0.000114	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.74e-05	0.000113	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.74e-05	0.000112	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.73e-05	0.000112	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	1.73e-05	0.000112	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	1.72e-05	0.000112	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	1.72e-05	0.000111	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	1.72e-05	0.000111	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.7e-05	0.00011	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	1.68e-05	0.000109	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	1.67e-05	0.000108	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.66e-05	0.000108	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	1.64e-05	0.000106	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	1.64e-05	0.000106	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	1.64e-05	0.000106	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	1.6e-05	0.000104	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	1.6e-05	0.000104	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.57e-05	0.000101	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	1.56e-05	0.000101	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	1.55e-05	0.0001	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	1.52e-05	9.84e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	1.52e-05	9.84e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	1.52e-05	9.83e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	1.49e-05	9.64e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	1.49e-05	9.63e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.49e-05	9.63e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	1.49e-05	9.62e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	1.49e-05	9.61e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.48e-05	9.59e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	1.46e-05	9.43e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	1.46e-05	9.42e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	1.44e-05	9.28e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	1.43e-05	9.25e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	1.43e-05	9.23e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.41e-05	9.15e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	1.4e-05	9.08e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.4e-05	9.05e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	1.4e-05	9.05e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—TH—epilepsy syndrome	1.39e-05	9.01e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.37e-05	8.88e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.37e-05	8.84e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	1.31e-05	8.46e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	1.28e-05	8.27e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	1.28e-05	8.27e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	1.25e-05	8.09e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	1.25e-05	8.09e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.22e-05	7.91e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.16e-05	7.52e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	1.16e-05	7.48e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.15e-05	7.42e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	1.13e-05	7.32e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.12e-05	7.22e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	1.11e-05	7.15e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	1.07e-05	6.94e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	1.05e-05	6.81e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	1.05e-05	6.79e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.04e-05	6.71e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	1.03e-05	6.66e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	1.03e-05	6.64e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.01e-05	6.51e-05	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	9.77e-06	6.32e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	9.68e-06	6.26e-05	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	9.56e-06	6.18e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	9.47e-06	6.13e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	9.4e-06	6.08e-05	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	9.35e-06	6.05e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	9.26e-06	5.99e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	9.2e-06	5.95e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	9.15e-06	5.92e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AGT—epilepsy syndrome	9.1e-06	5.89e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	8.99e-06	5.82e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	8.95e-06	5.79e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOE—epilepsy syndrome	8.92e-06	5.77e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	8.87e-06	5.74e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	8.75e-06	5.66e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	8.68e-06	5.61e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	8.49e-06	5.49e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	8.43e-06	5.46e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	8.25e-06	5.34e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	8.21e-06	5.31e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	8.07e-06	5.22e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	8.04e-06	5.2e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	7.86e-06	5.08e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—POMC—epilepsy syndrome	7.66e-06	4.95e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALB—epilepsy syndrome	6.98e-06	4.52e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	6.11e-06	3.95e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	5.24e-06	3.39e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	5.13e-06	3.32e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	5.01e-06	3.24e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.07e-06	1.99e-05	CbGpPWpGaD
